Celladon Corporation (CLDN) was a big mover last session, as the company saw its shares rise by over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now over 57% in the past one-month time frame.
This biopharmaceutical company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Celladon Corporation has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same industry include Actelion Ltd. (ALIOF), ANI Pharmaceuticals, Inc. (ANIP) and Biogen Idec Inc. (BIIB). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
CELLADON CORP (CLDN): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
Zacks Investment Research